The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Reversible Congenital Hypogonadotropic Hypogonadism in Patients with CHD7, FGFR1 or GNRHR Mutations
Open accessAbstract
BACKGROUND: Congenital hypogonadotropic hypogonadism (HH) is a rare cause for delayed or absent puberty. These patients may recover from HH spontaneously in adulthood. To date, it is not possible to predict who will undergo HH reversal later in life. Herein we investigated whether Finnish patients with reversal of congenital hypogonadotropic hypogonadism (HH) have common phenotypic or genotypic features. METHODS AND FINDINGS: Thirty-two male HH patients with anosmia/hyposmia (Kallmann Syndrome, KS; n = 26) or normal sense of smell (nHH; n = 6) were enrolled (age range, 18-61 yrs). The patients were clinically examined, and reversal of HH was assessed after treatment withdrawal. KAL1, FGFR1, FGF8, PROK2, PROKR2, CHD7, WDR11, GNRHR, GNRH1, KISS1R, KISS1, TAC3, TACR3, and LHβ were screened for mutations. Six HH patients (2 KS, 4 nHH) were verified to have reversal of HH. In the majority of cases, reversal occurred early in adulthood (median age, 23 yrs; range, 21-39 yrs). All had spontaneous testicular growth while on testosterone replacement therapy (TRT). One nHH subject was restarted on TRT due to a decline in serum T. Two reversal variants had a same GNRHR mutation (R262Q), which was accompanied by another GNRHR mutation (R139H or del309F). In addition, both of the KS patients had a mutation in CHD7 (p.Q51X) or FGFR1 (c.91+2T>A). CONCLUSIONS: Considerable proportion of patients with HH (8% of KS probands) may recover in early adulthood. Spontaneous testicular enlargement during TRT was highly suggestive for reversal of HH. Those with the GNRHR mutation R262Q accompanied by another GNRHR mutation may be prone to reversal, although even patients with a truncating mutation in CHD7 or a splice-site mutation in FGFR1 can recover. We recommend that all adolescents and young adults with congenital HH should be informed on the possibility of reversal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“CHD7 rare variants have previously been associated with milder reproductive phenotypes such as self-limiting delayed puberty (58) and reversal of hypogonadotropic hypogonadism (59).”
From Functional Hypogonadotropic Hypogonadism in Men: Underlying Neuroendocrine Mechanisms and Natural History (2019) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CHD7 cooperates with PBAF to control multipotent neural crest formation
Bajpai, R., Chen, D. A., Rada-Iglesias, A., Zhang, J., Xiong, Y., Helms, J., Chang, C.-P., Zhao, Y., Swigut, T., & Wysocka, J. (2010) · Nature · doi:10.1038/nature08733 · Cited by 616 · cited 1×
“Alternatively, CHD7 is one of the key genes for the formation of cranial neural crest [38], which has been suggested to be the source of ,30% of GnRH neurons in mice [39].”
BackgroundSchwanzel-Fukuda, M., Bick, D., & Pfaff, D. W. (1989) · Molecular Brain Research · doi:10.1016/0169-328x(89)90076-4 · Cited by 616
de Roux, N., Young, J., Misrahi, M., Genet, R., Chanson, P., Schaison, G., & Milgrom, E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711273372205 · Cited by 518
Seminara, S. B., Hayes, F. J., & Crowley, W. F. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.5.0344 · Cited by 414
Reversal of Idiopathic Hypogonadotropic Hypogonadism
Raivio, T., Falardeau, J., Dwyer, A., Quinton, R., Hayes, F. J., Hughes, V. A., Cole, L. W., Pearce, S. H., Lee, H., Boepple, P., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066494 · Cited by 413 · cited 4×
“However, up to 10% of HH patients may undergo reversal of hypogonadotropism and some of them even attain normal sperm count [6].”
BackgroundResultInfluentialSelf-citationKim, H.-G., Kurth, I., Lan, F., Meliciani, I., Wenzel, W., Eom, S. H., Kang, G. B., Rosenberger, G., Tekin, M., Ozata, M., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.09.005 · Cited by 338
Gianetti, E., Tusset, C., Noel, S. D., Au, M. G., Dwyer, A. A., Hughes, V. A., Abreu, A. P., Carroll, J., Trarbach, E., Silveira, L. F. G., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2320 · Cited by 294 · cited 1×
“For example, reversal variants have heterogeneous genetic background and may harbor mutation(s) in KAL1 [18], FGFR1 [16,20], PROK2 [19], GNRHR [15,17], and TAC3/TACR3 [21].”
BackgroundBlake, K. D., & Prasad, C. (2006) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-1-34 · Cited by 278
Forni, P. E., Taylor-Burds, C., Melvin, V. S., Williams, T., & Wray, S. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6087-10.2011 · Cited by 224 · cited 1×
“Alternatively, CHD7 is one of the key genes for the formation of cranial neural crest [38], which has been suggested to be the source of ,30% of GnRH neurons in mice [39].”
BackgroundJongmans, M., Van Ravenswaaij‐Arts, C., Pitteloud, N., Ogata, T., Sato, N., Claahsen‐van der Grinten, H., Van Der Donk, K., Seminara, S., Bergman, J., Brunner, H., et al. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2008.01107.x · Cited by 212 · cited 2×
“The latter are suggested to represent a mild end of CHARGE phenotypic spectrum due to overlapping features of these syndromes such as hypogonadism, anosmia, cleft lip and palate, hearing impairment, and semicircular canal hypoplasia [32,33].”
Background
Research works printed but not linked: 1
- I Rezvani, 1975, Delayed puberty and anosmia; coincidence or Kallmann variant?, Pediatr Res, 9, 224
Cited by
Boehm, U., Bouloux, P.-M., Dattani, M. T., de Roux, N., Dodé, C., Dunkel, L., Dwyer, A. A., Giacobini, P., Hardelin, J.-P., Juul, A., et al. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.112 · Cited by 874
Self-citationPaediatric and adult-onset male hypogonadism
Salonia, A., Rastrelli, G., Hackett, G., Seminara, S. B., Huhtaniemi, I. T., Rey, R. A., Hellstrom, W. J. G., Palmert, M. R., Corona, G., Dohle, G. R., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0087-y · Cited by 286
Sidhoum, V. F., Chan, Y.-M., Lippincott, M. F., Balasubramanian, R., Quinton, R., Plummer, L., Dwyer, A., Pitteloud, N., Hayes, F. J., Hall, J. E., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2809 · Cited by 163
Valdes‐Socin, H., Rubio-Almanza, M., Fernández-Ladreda, M. T., Debray, F. G., Bours, V., & Beckers, A. M. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00109 · Cited by 148
“described in 2012, a KS patient with a truncating CHD7 mutation that underwent a reversal of central hypogonadism after therapy discontinuation (15).”
BackgroundVarimo, T. J., Miettinen, P. J., Känsäkoski, J., Raivio, T., & Hero, M. T. (2016) · Human Reproduction · doi:10.1093/humrep/dew294 · Cited by 115
“Overall, 11 boys and 5 girls were diagnosed with CHH and 12 of them were screened for CHH genes (Laitinen et al., 2011, 2012; Hero et al., 2012, 2015; Varimo et al., 2016).”
BackgroundSelf-citation
Metadata
- Authors
- Laitinen, E.-M., Tommiska, J., Sane, T., Vaaralahti, K., Toppari, J., & Raivio, T.
- Affiliations
- University of Helsinki (FI)
- Helsinki University Hospital (FI)
- University of Turku (FI)
- Corresponding author
- Raivio, Taneli
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-06-19
- Volume
- 7
- Issue
- 6
- Pages
- e39450
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3378565
- OpenAlex
- W1982199134
- Cited by
- 89
- References
- 39
- Citations by year
- 2025: 2 · 2024: 3 · 2023: 6 · 2022: 5 · 2021: 7 · 2020: 8 · 2019: 6 · 2018: 4 · 2017: 7 · 2016: 8 · 2015: 14 · 2014: 14 · 2013: 3 · 2012: 2
- FWCI
- 12.33
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Työväentutkimus Vuosikirja (submittedVersion)
- Funders
- Helsingin Yliopisto
- Helsingin ja Uudenmaan Sairaanhoitopiiri
- Suomen Kulttuurirahasto
- Emil Aaltosen Säätiö
- Lastentautien Tutkimussäätiö
- Helsingin Yliopiston Tiedesäätiö
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Keywords
- congenital hypogonadotropic hypogonadism, Kallmann syndrome, anosmia, CHD7 mutations, FGFR1 mutation, testosterone replacement therapy, puberty onset, Finnish patients
- MeSH terms
- Adolescent, Adult, DNA Helicases, DNA-Binding Proteins, Genotype, Humans, Hypogonadism, Male, Mutation, Phenotype, Receptors, LHRH, Kallmann Syndrome, Hormone Replacement Therapy, Receptor, Fibroblast Growth Factor, Type 1, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reversible Congenital Hypogonadotropic Hypogonadism in Patients with CHD7, FGFR1 or GNRHR Mutations. https://app.cochat.ai/papers/10.1371/journal.pone.0039450
- The paper
- Laitinen, E.-M., Tommiska, J., Sane, T., Vaaralahti, K., Toppari, J., & Raivio, T. (2012). Reversible Congenital Hypogonadotropic Hypogonadism in Patients with CHD7, FGFR1 or GNRHR Mutations. PLoS ONE. https://doi.org/10.1371/journal.pone.0039450
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.